Notably, polymorphisms within the LRRK2 locus are associated with PD susceptibility [14] and the age at onset (AOO) in progressive supranuclear palsy [15], and these may influence LRRK2 expression, protein interactions, and kinase activation [16]. This evidence concerns the gene LRRK2 and Parkinson disease.